CSL (CSL) vs Eli Lilly (LLY)
CSL (CSL) and Eli Lilly (LLY) side by side: both in Healthcare, listed on Australian Securities Exchange and New York Stock Exchange. Eli Lilly is the larger of the two by approximate market capitalization (about 18.6×).
| Field | CSL | Eli Lilly |
|---|---|---|
| Legal name | CSL Limited | Eli Lilly and Company |
| Ticker | CSL | LLY |
| Exchange | Australian Securities Exchange XASX | New York Stock Exchange XNYS |
| Jurisdiction | Australia | United States |
| Sector | Healthcare | Healthcare |
| Industry | Plasma therapies & vaccines | Pharmaceuticals |
| Market cap ≈ | $59.4bn | $1.1tn |
| Founded | 1916 | 1876 |
| Reporting currency | AUD | USD |
| LEI | 529900ECSECK5ZDQTE14 | FRDRIPF3EKNDJ2CQJL29 |
| ISIN | AU000000CSL8 | US5324571083 |
| FIGI | BBG001S7YNK1 | BBG001S5STL8 |
| Index membership | — | S&P 500 |
| Held by (covered funds) | — | 1 |
CSL
Australian biotech and one of the world's largest makers of plasma-derived therapies (CSL Behring), also active in influenza vaccines (Seqirus) and iron-deficiency and nephrology treatments (Vifor).
Eli Lilly
Pharmaceutical maker; GLP-1 metabolic drugs (Mounjaro, Zepbound), oncology and neuroscience.
Market caps are computed from each issuer's own filed share count times the close on 2026-08-28, not copied from a vendor; LEI from GLEIF (CC0), ISIN read from each issuer's own primary listing document with its ISO 6166 check digit validated, FIGI from OpenFIGI, MIC from the ISO 10383 registry — full provenance on Sources. Not real-time, not investment advice. Both sides as data: /api/v1/companies/csl · /api/v1/companies/eli-lilly